Table 3 Number of patients classified by estrogen receptor and progesterone receptor statuses before and after neoadjuvant chemotherapy

From: Change in the hormone receptor status following administration of neoadjuvant chemotherapy and its impact on the long-term outcome in patients with primary breast cancer

 

(ER, PgR) after NAC

(ER, PgR) before NAC

(+, +)

(+, −)

(−, +)

(−, −)

(+, +)

69 (18.8)

41 (11.1)

3 (0.8)

10 (2.7)

(+, −)

18 (4.9)

27 (7.3)

1 (0.3)

7 (1.9)

(−, +)

11 (3.0)

6 (1.6)

8 (2.2)

13 (3.5)

(−, −)

6 (1.6)

11 (3.0)

12 (3.3)

125 (34.0)

  1. Abbreviations: ER=estrogen receptor; HER2=human epidermal receptor 2; PgR=progesterone receptor.
  2. Figures in parentheses are percentage of patients.
Back to article page